ES2210592T3 - Compuestos con una mejorada actividad inductora de cartilago y/o hueso. - Google Patents
Compuestos con una mejorada actividad inductora de cartilago y/o hueso.Info
- Publication number
- ES2210592T3 ES2210592T3 ES97951919T ES97951919T ES2210592T3 ES 2210592 T3 ES2210592 T3 ES 2210592T3 ES 97951919 T ES97951919 T ES 97951919T ES 97951919 T ES97951919 T ES 97951919T ES 2210592 T3 ES2210592 T3 ES 2210592T3
- Authority
- ES
- Spain
- Prior art keywords
- bone
- protein
- proteins
- matrix
- tgf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 17
- 230000001939 inductive effect Effects 0.000 title claims abstract description 14
- 210000000988 bone and bone Anatomy 0.000 title claims description 80
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 111
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 109
- 239000000463 material Substances 0.000 claims abstract description 49
- 239000011159 matrix material Substances 0.000 claims abstract description 42
- 239000007943 implant Substances 0.000 claims abstract description 37
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 37
- 230000000694 effects Effects 0.000 claims abstract description 27
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 230000000975 bioactive effect Effects 0.000 claims abstract description 15
- 238000011282 treatment Methods 0.000 claims abstract description 13
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 11
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 10
- 201000010099 disease Diseases 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 4
- 210000000845 cartilage Anatomy 0.000 claims description 30
- 108020004414 DNA Proteins 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 15
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 15
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 15
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 15
- 229910010293 ceramic material Inorganic materials 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 12
- 229910019142 PO4 Inorganic materials 0.000 claims description 11
- 230000002138 osteoinductive effect Effects 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 230000006378 damage Effects 0.000 claims description 8
- 239000000411 inducer Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 238000009826 distribution Methods 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 210000002808 connective tissue Anatomy 0.000 claims description 6
- 239000000539 dimer Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 230000007547 defect Effects 0.000 claims description 4
- 230000007850 degeneration Effects 0.000 claims description 4
- 208000028169 periodontal disease Diseases 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 3
- 238000013270 controlled release Methods 0.000 claims description 3
- 208000031513 cyst Diseases 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000000833 heterodimer Substances 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 230000008595 infiltration Effects 0.000 claims description 3
- 238000001764 infiltration Methods 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 208000014674 injury Diseases 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 2
- 230000022159 cartilage development Effects 0.000 claims description 2
- 201000009890 sinusitis Diseases 0.000 claims description 2
- 239000011877 solvent mixture Substances 0.000 claims description 2
- 238000000859 sublimation Methods 0.000 claims description 2
- 230000008022 sublimation Effects 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 239000000919 ceramic Substances 0.000 abstract description 14
- 101100472152 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) REL1 gene Proteins 0.000 abstract description 12
- 230000006698 induction Effects 0.000 abstract description 8
- 238000011161 development Methods 0.000 abstract description 3
- 239000004744 fabric Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 92
- 239000012071 phase Substances 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 13
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 13
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 8
- 239000011575 calcium Substances 0.000 description 7
- 238000005245 sintering Methods 0.000 description 7
- 230000011164 ossification Effects 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 108010059616 Activins Proteins 0.000 description 5
- 239000000488 activin Substances 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- UBWXUGDQUBIEIZ-UHFFFAOYSA-N (13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl) 3-phenylpropanoate Chemical compound CC12CCC(C3CCC(=O)C=C3CC3)C3C1CCC2OC(=O)CCC1=CC=CC=C1 UBWXUGDQUBIEIZ-UHFFFAOYSA-N 0.000 description 4
- 102000005606 Activins Human genes 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 150000001945 cysteines Chemical class 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 3
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 2
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 2
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 2
- 102100022545 Bone morphogenetic protein 8B Human genes 0.000 description 2
- 108010041881 Growth Differentiation Factor 10 Proteins 0.000 description 2
- 108010090254 Growth Differentiation Factor 5 Proteins 0.000 description 2
- 108010050777 Growth Differentiation Factors Proteins 0.000 description 2
- 102000014015 Growth Differentiation Factors Human genes 0.000 description 2
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 2
- 101710194452 Growth/differentiation factor 11 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000002746 Inhibins Human genes 0.000 description 2
- 108010004250 Inhibins Proteins 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 description 2
- 238000002144 chemical decomposition reaction Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000893 inhibin Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000010587 phase diagram Methods 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 1
- 108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 description 1
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
- 102100028726 Bone morphogenetic protein 10 Human genes 0.000 description 1
- 101710118482 Bone morphogenetic protein 10 Proteins 0.000 description 1
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102100040897 Embryonic growth/differentiation factor 1 Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108010090296 Growth Differentiation Factor 1 Proteins 0.000 description 1
- 108010090290 Growth Differentiation Factor 2 Proteins 0.000 description 1
- 108010090293 Growth Differentiation Factor 3 Proteins 0.000 description 1
- 108010090250 Growth Differentiation Factor 6 Proteins 0.000 description 1
- 102000004858 Growth differentiation factor-9 Human genes 0.000 description 1
- 108090001086 Growth differentiation factor-9 Proteins 0.000 description 1
- 101710194458 Growth/differentiation factor 10 Proteins 0.000 description 1
- 102100040892 Growth/differentiation factor 2 Human genes 0.000 description 1
- 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 1
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
- 102100035363 Growth/differentiation factor 7 Human genes 0.000 description 1
- 101710204283 Growth/differentiation factor 7 Proteins 0.000 description 1
- 241000424725 Heide Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 description 1
- 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 1
- 102100026818 Inhibin beta E chain Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 101150067309 bmp4 gene Proteins 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- -1 by a side Chemical compound 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- FDFYYWMHPJTGEO-UHFFFAOYSA-K tetracalcium;phosphate Chemical class [Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O FDFYYWMHPJTGEO-UHFFFAOYSA-K 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
- A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19647853 | 1996-11-19 | ||
| DE19647853A DE19647853A1 (de) | 1996-11-19 | 1996-11-19 | Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2210592T3 true ES2210592T3 (es) | 2004-07-01 |
Family
ID=7812132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97951919T Expired - Lifetime ES2210592T3 (es) | 1996-11-19 | 1997-11-19 | Compuestos con una mejorada actividad inductora de cartilago y/o hueso. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7365051B2 (https=) |
| EP (1) | EP0942758B1 (https=) |
| JP (1) | JP3807749B2 (https=) |
| AU (1) | AU5553398A (https=) |
| DE (2) | DE19647853A1 (https=) |
| ES (1) | ES2210592T3 (https=) |
| WO (1) | WO1998021972A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4388602B2 (ja) † | 1997-02-07 | 2009-12-24 | ストライカー コーポレイション | マトリクスを含まない骨形成デバイス、移植片、およびその使用方法 |
| DE19944681A1 (de) * | 1999-08-20 | 2001-03-01 | Metz Stavenhagen Peter | Knochenersatzstoff zur Implantation im menschlichen oder tierischen Körper |
| CH695043A5 (de) * | 2000-03-10 | 2005-11-30 | Technology Finance Corp | Implantat, das einen Körper aus nichtresorbierbarem bioaktivem Material umfasst. |
| ES2247423T5 (es) * | 2001-11-19 | 2015-12-30 | Scil Technology Gmbh | Método de producción de un dispositivo recubierto homogéneamente que tiene propiedades osteoinductoras y osteoconductoras |
| ATE322916T1 (de) | 2002-09-10 | 2006-04-15 | Scil Technology Gmbh | Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat |
| AU2003277593A1 (en) * | 2002-11-07 | 2004-06-07 | Ichiro Ono | Therapeutic device for osteogenesis |
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| EP1604693A1 (en) | 2004-06-09 | 2005-12-14 | Scil Technology GmbH | In situ forming scaffold, its manufacturing and use |
| EP1604694A1 (en) * | 2004-06-09 | 2005-12-14 | Scil Technology GmbH | Composite device having osteoinductive and osteoconductive properties |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| JP2009508596A (ja) | 2005-09-19 | 2009-03-05 | ヒストジェニックス コーポレイション | 細胞支持基材及びその調製方法 |
| CN101330934B (zh) * | 2005-12-14 | 2013-03-20 | Scil技术有限公司 | 一种用于骨再生的可模压的生物材料及其制备方法和用途 |
| DE102005060761B4 (de) * | 2005-12-16 | 2007-10-25 | Alexakis, Antonis, Dr. med. dent. | Formteil zur Neubildung von Knochenmaterial |
| EP1880731A1 (en) | 2006-07-18 | 2008-01-23 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Human growth and differentiation factor GDF-5 |
| US7723291B2 (en) * | 2006-07-27 | 2010-05-25 | Warsaw Orthopedic, Inc. | Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix |
| EP3345607B1 (en) * | 2006-12-29 | 2022-10-26 | Ossifi-Mab LLC | Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| HRP20120698T1 (hr) * | 2007-01-25 | 2013-09-30 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Uporaba dgf-5 za poboljšanje ili održavanje izgleda kože |
| US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| US20090061002A1 (en) * | 2007-09-05 | 2009-03-05 | Venbrocks Rudolf A | Calcium phospate based delivery of growth and differentiation factors to compromised bone |
| WO2009111069A1 (en) | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| KR100991203B1 (ko) * | 2010-05-10 | 2010-11-01 | 심영복 | 골형성 단백질의 정제 방법 |
| EP2537538A1 (en) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
| EP2602264A1 (en) | 2011-12-05 | 2013-06-12 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | GDF-5 mutant for inducing cartilage formation |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| NZ746109A (en) | 2016-12-30 | 2022-12-23 | Biogend Therapeutics Co Ltd | Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof |
| US11324806B2 (en) | 2018-10-19 | 2022-05-10 | Warsaw Orthopedic, Inc. | Sustained delivery of a growth differentiation factor |
| IL293988A (en) | 2019-12-18 | 2022-08-01 | Merck Patent Gmbh | Use of a gdf-5 mutant in the treatment of pain and cartilage destruction |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4596574A (en) * | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
| US4681763A (en) * | 1985-06-11 | 1987-07-21 | University Of Medicine And Dentistry Of New Jersey | Composition for stimulating bone growth |
| DE3810803A1 (de) * | 1988-03-30 | 1989-10-12 | Battelle Institut E V | Verfahren zur herstellung eines synthetischen knochenmaterials mit koerpereigenen eigenschaften |
| WO1991005802A1 (en) | 1989-10-17 | 1991-05-02 | Creative Biomolecules, Inc. | Osteogenic devices |
| IL110589A0 (en) * | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
| US6302913B1 (en) | 1994-05-24 | 2001-10-16 | Implico B.V. | Biomaterial and bone implant for bone repair and replacement |
| US5866155A (en) * | 1996-11-20 | 1999-02-02 | Allegheny Health, Education And Research Foundation | Methods for using microsphere polymers in bone replacement matrices and composition produced thereby |
-
1996
- 1996-11-19 DE DE19647853A patent/DE19647853A1/de not_active Withdrawn
-
1997
- 1997-11-19 AU AU55533/98A patent/AU5553398A/en not_active Abandoned
- 1997-11-19 JP JP52321598A patent/JP3807749B2/ja not_active Expired - Fee Related
- 1997-11-19 DE DE59711220T patent/DE59711220D1/de not_active Revoked
- 1997-11-19 WO PCT/EP1997/006463 patent/WO1998021972A2/de not_active Ceased
- 1997-11-19 ES ES97951919T patent/ES2210592T3/es not_active Expired - Lifetime
- 1997-11-19 EP EP97951919A patent/EP0942758B1/de not_active Revoked
-
2005
- 2005-03-16 US US11/080,494 patent/US7365051B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU5553398A (en) | 1998-06-10 |
| DE59711220D1 (de) | 2004-02-19 |
| WO1998021972A3 (de) | 1998-09-17 |
| EP0942758A2 (de) | 1999-09-22 |
| JP3807749B2 (ja) | 2006-08-09 |
| US7365051B2 (en) | 2008-04-29 |
| US20050169965A1 (en) | 2005-08-04 |
| JP2001505097A (ja) | 2001-04-17 |
| DE19647853A1 (de) | 1998-05-20 |
| EP0942758B1 (de) | 2004-01-14 |
| WO1998021972A2 (de) | 1998-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2210592T3 (es) | Compuestos con una mejorada actividad inductora de cartilago y/o hueso. | |
| Khan et al. | Clinical applications of bone graft substitutes | |
| KR101105908B1 (ko) | 골유도 단백질용 칼슘 포스페이트 전달 부형제 | |
| ES2330108T3 (es) | Una nueva composcion de sustitutivo de hueso. | |
| ES2429889T3 (es) | Composición farmacéutica que comprende una pasta de endurecimiento in situ, su fabricación y uso | |
| AU746591B2 (en) | Hardenable ceramic hydraulic cement | |
| ES2209820T3 (es) | Composiciones esponjosas osteogenicas altamente mineralizadas, y usos de las mismas. | |
| ES2902872T3 (es) | Matrices suplementadas para la reparación de fracturas óseas | |
| Maus et al. | BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep | |
| ES2247423T3 (es) | Dispositivo recubierto homogeneamente que tiene propiedades osteoinductoras y osteoconductoras. | |
| AU2002314928A1 (en) | Calcium phosphate delivery vehicles for osteoinductive proteins | |
| JPH11506659A (ja) | 生物学的互換ヒドロキシアパタイト製剤及びその使用 | |
| KR20120006997A (ko) | 뼈 이식재 대체물과 조합된 제올라이트를 사용한 뼈 성장의 조절 | |
| ES2501965T3 (es) | Preparación para la regeneración de defectos óseos posoperatorios y postraumáticos | |
| HU226201B1 (en) | Cartilage/bone inducing materials for reparation | |
| Aqib et al. | Metal-Doped brushite cement for bone regeneration | |
| JPH10151188A (ja) | 骨形成用移植体 | |
| EP2200537B1 (en) | Calcium phosphate based delivery of growth and differentiation factors to compromised bone | |
| WO1997023612A2 (de) | Zielgerichtete verbindungen mit knorpel- und/oder knocheninduzierender aktivität | |
| Lee | A Pilot Study to Compare the Activity of Different Bone Morphogenetic Protein Bioimplants In Vivo | |
| Lullo | Source and Carrier Effect on the Bioactivity of BMP Bio-implants | |
| Tölli | Reindeer-derived bone protein extract in the healing of bone defects: evaluation of various carrier materials and delivery systems | |
| Mekhail et al. | Bone Graft Substitutes in Spinal Surgery |